What’s Next for Liquid Biopsy Tests?

Aurora, Colo.-based Foresight Diagnostics, which was co-founded in 2020 by Jake Chabon, PhD, Max Diehn, MD, PhD, Ash Alizadeh, MD, PhD, and David Kurtz, MD PhD, has developed a new liquid biopsy test that can identify the earliest hint of cancer recurrence.